Drug · DIN 02407477
MYLAN-NITRO PATCH 0.8
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since June 4, 2013; first marketed June 4, 2013.
- Drug Identification Number (DIN)
- 02407477
- Company (DIN owner)
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Schedule
- Ethical
- Dosage form
- Patch (Extended-Release)
- Route
- Transdermal
- Therapeutic class (ATC)
- Glyceryl trinitrate C01DA02
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| NITROGLYCERIN | 0.8 MG | HOUR |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 4, 2013: NOC 14420Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “mylan-nitro”. A notice may cover another product or only some lots: read it to see what it covers.
- Mylan-Nitro Sublingual Spray (2014-10-14)October 22, 2014 · Drugs · Product safety · Type I
- Mylan-Nitro Sublingual Spray 0.4 mg Per Metered Dose - Unaffected Product Has Now Become Available - For Health ProfessionalsOctober 14, 2014 · Drugs · Product safety
- Mylan-Nitro Sublingual Spray 0.4 mg Per Metered Dose - Additional Information on the Recall - For Health ProfessionalsSeptember 22, 2014 · Drugs · Product safety